Acta Pharmacologica Sinica, Published online: 08 June 2026; doi:10.1038/s41401-026-01858-x Time-resolved proteomic and phosphoproteomic analysis reveals convergent and divergent biological perturbations induced by FDA-approved CDK4/6 inhibitors in hormone receptor-positive breast cancers